Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import to Russia (January 2018)

Thursday, March 29, 2018

In January 2018, Russia imported 30.6 bln RUB worth of ready-made drugs (free circulation prices), which is in monetary terms 1.5% higher than that of January 2017, and 6.5 bln RUB worth of in-bulk drugs, which is 4.4% lower than that of January 2017.

In physical terms, Russia imported 126.8 mln units of ready-made drugs, which is 0.2% higher than that of January 2017. As for MDU (minimum dosage units), Russia imported 2.8 bln MDUs of ready-made and in-bulk drugs. The dynamics of the in-bulk import are 58%, which contributed to the positive dynamics of the import if calculated in MDU (+4%). However, the import of ready-made drugs has fallen by 3.7% if calculated in MDU.

Valenta and Merck Group were among the leaders in the in-bulk import in January 2018. In physical terms, the import of Valenta in-bulk drugs has increased by nearly 60 times thanks to Trimedat. The import of Merck Group in-bulk drugs has increased by 35 times thanks to Concor and Glucophage.

The leader in the import of ready-made drugs is Gedeon Richter, with a 3.1 times growth, followed by Shreya Life Sciences, with a 2.2 times growth. Mydocalm and Airtal contributed to the progress of Gedeon Richter, while Suprima-LOR and Penzital contributed to Shreya Life Sciences.

Read more about pharmaceutical drug import to Russia (December results) here: http://rncph.com/news/16_02_2018_2

Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance and VAT, RUB (January 2017 – January 2018)

Share: